---
title: "Phio Pharmaceuticals jumps 9% after-hours on INTASYL patent wins"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292823054.md"
description: "Phio Pharma (PHIO) rose 9% after-hours after securing multiple INTASYL patents in the US, Canada, and Japan."
datetime: "2026-07-15T22:41:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292823054.md)
  - [en](https://longbridge.com/en/news/292823054.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292823054.md)
generator: "portal-rs"
---

# Phio Pharmaceuticals jumps 9% after-hours on INTASYL patent wins

Phio Pharmaceuticals(PHIO.US) 盘后涨**8.93%**，现报**0.9238 美元**。

公司宣布 INTASYL 化合物在美国、加拿大和日本获得多项专利许可通知及授予决定，加强全球专利保护。目前专利组合已涵盖 54 项授权专利，涉及 INTASYL 化学和免疫肿瘤学靶点。CEO Robert Bitterman 表示这些进展支持战略合作伙伴关系的建立和商业化努力。

### Related Stocks

- [PHIO.US](https://longbridge.com/en/quote/PHIO.US.md)

## Related News & Research

- [Phio Pharmaceuticals (NASDAQ:PHIO) Director Ronald Todd Plott Buys 15,000 Shares of Stock](https://longbridge.com/en/news/296616090.md)
- [Top Executive Makes Bold Insider Move at Biotech Firm](https://longbridge.com/en/news/296434198.md)
- [Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares](https://longbridge.com/en/news/296394316.md)
- [Phio Pharma wins U.S. patent allowance for BRD4-targeting INTASYL compound PH-894](https://longbridge.com/en/news/295525767.md)
- [Phio net loss widens to $4.14 million in Q2 FY26](https://longbridge.com/en/news/295141049.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**